CDMRP: Peer Reviewed Medical Research Program (PRMRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Peer Reviewed Medical Research Program (PRMRP) is a pre-announcement from the Department of Defense indicating substantial upcoming funding across a wide range of medical research topics relevant to military health. This is an early signal to begin preparing—applications are not yet open, and deadlines are not specified in this pre-announcement. Once released on Grants.gov, these opportunities will move quickly and require pre-applications or letters of intent.

This program supports everything from early-stage discovery through large-scale clinical trials, with awards ranging from $385,000 up to $20M+ depending on mechanism. Founders and research teams should begin aligning projects now to be competitive when announcements drop.

How much funding would I receive?

Funding varies significantly by award mechanism:

  • Clinical Trial Award

    • Planning Phase: up to $800,000

    • Level 1: up to $6M

    • Level 2: up to $10M

    • Level 3: up to $20M

  • Discovery Award

    • Up to $385,000

  • Impact Award

    • Single PI: up to $2.8M

    • Partnering PI: up to $3.6M

  • Lifestyle and Applied Health Research Award

    • Up to $4.2M

  • Platform Clinical Translation Award

    • Up to $15M (with only $8M guaranteed from FY26 funds)

  • Research Advancement Award

    • Up to $1.4M

  • Technology/Therapeutic Development Award

    • Up to $5.6M

All amounts are total costs (direct + indirect).

What could I use the funding for?

Funding supports a broad spectrum of medical research aligned to congressionally mandated topic areas, including (not exhaustive):

  • PTSD, traumatic brain injury, suicide prevention

  • Burn pit exposure, respiratory health

  • Rare diseases (e.g., Rett Syndrome, Fragile X, mitochondrial disease)

  • Chronic conditions (e.g., diabetes-related areas not explicitly listed, IBD, fibromyalgia-related analogs where applicable)

  • Women’s health (e.g., endometriosis, maternal mental health)

  • Neurological and musculoskeletal conditions

Use cases depend on the mechanism:

  • Discovery Award: High-risk, early-stage concepts (no preliminary data)

  • Impact Award: Hypothesis-driven work with preliminary data

  • Clinical Trial Award: Phase 0–3 trials

  • Technology/Therapeutic Development: Translating preclinical work into products

  • Platform Clinical Translation: Multi-indication platforms

  • Lifestyle and Applied Health: Quality of life, behavioral, and applied interventions

Projects must align to at least one specified topic area.

Are there any additional benefits I would receive?

  • Validation from the Department of Defense and CDMRP

  • Access to non-dilutive capital at scale (up to $20M)

  • Opportunity to support military-relevant health outcomes

  • Structured pathways for clinical translation and regulatory readiness (e.g., IND/IDE planning support under Clinical Trial Award)

Additional benefits are not further specified in the pre-announcement.

What is the timeline to apply and when would I receive funding?

  • This is a pre-announcement only

  • Funding opportunity announcements will be released on Grants.gov

  • Pre-application and full application deadlines are not specified in this pre-announcement

  • Submission will require:

    • Pre-application (e.g., preproposal or letter of intent depending on mechanism)

    • Full application (often by invitation only)

  • Periods of performance:

    • Range from 2 years to 4 years depending on mechanism

    • Planning phases up to 18 months

Exact award start timelines are not specified.

Where does this funding come from?

  • FY26 Defense Appropriations Act

  • Administered by:

    • Defense Health Agency (DHA) Research and Development

    • Medical Research and Development Command (MRDC)

    • Managed through the Congressionally Directed Medical Research Programs (CDMRP)

Who is eligible to apply?

  • Independent investigators at all career levels

  • Applies across all award mechanisms

No additional institutional, geographic, or organizational eligibility restrictions are specified in this pre-announcement.

What companies and projects are likely to win?

Based strictly on the solicitation:

  • Projects that:

    • Align directly with congressionally mandated topic areas

    • Demonstrate clear relevance to military health

    • Show high impact and scientific merit

  • Competitive profiles by mechanism:

    • Discovery: Bold, untested ideas without preliminary data

    • Impact: Strong preliminary data + near-term impact potential

    • Clinical Trial: Well-developed interventions ready for human testing

    • Technology/Therapeutic Development: Clear product-oriented outcomes

    • Platform Clinical Translation: Solutions addressing multiple topic areas

  • Teams:

    • May include clinician researchers or industry partners (required in some partnering options)

Further selection criteria are not specified in this pre-announcement.

Are there any restrictions I should know about?

Key restrictions vary by mechanism:

  • Clinical Trial Award

    • Cannot support preclinical research

    • Requires regulatory approvals (e.g., IND/IDE) where applicable

  • Discovery Award

    • Cannot include preliminary data

    • Cannot support clinical trials

  • Impact Award

    • Cannot support clinical trials

  • Lifestyle and Applied Health Research Award

    • Cannot support animal studies

  • Technology/Therapeutic Development Award

    • Cannot support clinical trials

  • Research Advancement Award

    • Cannot support clinical trials

  • All applications:

    • Must align to specified topic areas

    • Require pre-application submission (preproposal or LOI depending on mechanism)

How long will it take me to prepare an application?

Not explicitly specified, but based on required steps:

  • Pre-application required (LOI or preproposal)

  • Full applications often by invitation only

  • Clinical trial applications may require:

    • Regulatory documentation (e.g., IND/IDE)

Exact preparation timelines are not specified in the pre-announcement.

How can BW&CO help?

BW&CO can support:

  • Opportunity qualification against PRMRP mechanisms

  • Topic area alignment and positioning

  • Preproposal / LOI development

  • Full application strategy and narrative development

  • Clinical and product translation positioning

  • Partnering strategy (e.g., clinician or industry PI alignment)

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

Previous
Previous

Golden Dome for America - Department of War CSO

Next
Next

CDMRP: Combat Readiness–Medical Research Program (CRRP)